A previous study showed that the replacement of miR-143-3p in bladder cancer cells reduced AKT1 levels, an effect that was further enhanced by simultaneously restoring miR-145-5p, a miRNA family member of miR-143-3p [54]. Here, AKT1 is linked to urinary bladder carcinoma.